Prospective Study Evaluating Na18F-Positron Emission Tomography/Computed Tomography (NaF-PET/CT) in Predicting Clinical Outcomes and Survival in Advanced Prostate Cancer

This prospective pilot study evaluated the ability of sodium fluoride (Na(18)F) positron emission tomography/computed tomography (NaF-PET/CT) to detect and monitor bone metastases over time and its correlation with clinical outcomes and survival in advanced prostate cancer.

PATIENTS AND METHODS - Sixty prostate cancer patients, including 30 with and 30 without known bone metastases by conventional imaging underwent NaF-PET/CT at baseline, 6, and 12 months. Positive lesions were verified on follow-up scans. Changes in standardized uptake values (SUV) and lesion number were correlated with prostate-specific antigen (PSA) change, clinical impression, and overall survival (OS).

RESULTS - Sixty patients underwent 170 NaF-PET/CT scans. Significant associations included SUV and PSA percent change at 6 (P = 0. 014) and 12 months (P = 0. 0005); SUV maximal percent change from baseline and clinical impression at 6 months (P = 0. 0147) and 6-12 months (P = 0. 0053); SUV change at 6 months and OS (P = 0. 018); number of lesions on NaF-PET/CT and clinical impression at baseline (P < 0. 0001), 6 (P = 0. 0078), and 12 months (P = 0. 0029); number of lesions on NaF-PET/CT per patient at baseline and OS (P = 0. 017). In an exploratory analysis, paired (99m)Tc-MDP bone scans (TcBS) were available in 35 patients at baseline, 19 at 6 months, and 14 at 12 months (n = 68 scans). Malignant lesions on NaF-PET/CT (n =57) were classified on TcBS as malignant 65%; indeterminate 25%; and negative 10%. Additionally 65% of paired scans showed more lesions on NaF-PET/CT than on TcBS.

CONCLUSIONS - Baseline number of malignant lesions and changes in SUV on follow-up NaF-PET/CT significantly correlates with clinical impression and OS. NaF-PET/CT detects more bone metastases earlier than TcBS and enhances detection of new bone disease in high-risk patients.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2016 Jan 21 [Epub ahead of print]

Andrea B Apolo, Liza Lindenberg, Joanna H Shih, Esther Mena, Joseph W Kim, Jong C Park, Anna Alikhani, Yolanda Y McKinney, Juanita Weaver, Baris Turkbey, Howard L Parnes, Lauren V Wood, Ravi A Madan, James L Gulley, William L Dahut, Karen A Kurdziel, Peter L Choyke

National Cancer Institute, United States;, National Cancer Institute, United States;, National Cancer Institute, United States;, National Cancer Institute, United States; National Cancer Institute, United States;, National Cancer Institute, United States;, National Cancer Institute, United States;, National Cancer Institute, United States;, National Cancer Institute, United States;, National Cancer Institute, United States;, National Cancer Institute, United States;, National Cancer Institute, United States;, National Cancer Institute, United States;, National Cancer Institute, United States;, National Cancer Institute, United States;

PubMed

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe